Live feed
Filing
SC 13D
SC 13D0001571049-16-019239·CELGENE CORP /DE/
Schedule 13D ownership disclosure
CRISPR Therapeutics AG
Security class unavailable · CUSIP: H17182108
Event date: 2016-10-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001571049-16-019239
- Form type
- SC 13D
- Filer
- CELGENE CORP /DE/
- CIK
- CIK 816284
- Filed
- Oct 31, 2016
- Reporting period
- Oct 24, 2016
- Description
- Schedule 13D beneficial ownership